CA2221341C - Submicron liposome suspensions obtained from preliposome lyophilizates - Google Patents

Submicron liposome suspensions obtained from preliposome lyophilizates Download PDF

Info

Publication number
CA2221341C
CA2221341C CA002221341A CA2221341A CA2221341C CA 2221341 C CA2221341 C CA 2221341C CA 002221341 A CA002221341 A CA 002221341A CA 2221341 A CA2221341 A CA 2221341A CA 2221341 C CA2221341 C CA 2221341C
Authority
CA
Canada
Prior art keywords
preliposome
lyophilate
liposomes
surfactant
annamycin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002221341A
Other languages
English (en)
French (fr)
Other versions
CA2221341A1 (en
Inventor
Yiyu Zou
Waldemar Priebe
Roman Perez-Soler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
University of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System filed Critical University of Texas System
Publication of CA2221341A1 publication Critical patent/CA2221341A1/en
Application granted granted Critical
Publication of CA2221341C publication Critical patent/CA2221341C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002221341A 1995-06-06 1996-06-06 Submicron liposome suspensions obtained from preliposome lyophilizates Expired - Fee Related CA2221341C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/468,791 US5902604A (en) 1995-06-06 1995-06-06 Submicron liposome suspensions obtained from preliposome lyophilizates
US08/468,791 1995-06-06
PCT/US1996/009830 WO1996039121A1 (en) 1995-06-06 1996-06-06 Submicron liposome suspensions obtained from preliposome lyophilizates

Publications (2)

Publication Number Publication Date
CA2221341A1 CA2221341A1 (en) 1996-12-12
CA2221341C true CA2221341C (en) 2009-04-21

Family

ID=23861262

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002221341A Expired - Fee Related CA2221341C (en) 1995-06-06 1996-06-06 Submicron liposome suspensions obtained from preliposome lyophilizates

Country Status (6)

Country Link
US (2) US5902604A (enExample)
EP (2) EP1800665A3 (enExample)
JP (1) JPH11507369A (enExample)
AU (1) AU710113B2 (enExample)
CA (1) CA2221341C (enExample)
WO (1) WO1996039121A1 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002509102A (ja) * 1998-01-16 2002-03-26 バイオミラ・ユーエスエイ・インコーポレイテッド リポマトリックス製剤
AU773515B2 (en) * 1999-02-08 2004-05-27 Alza Corporation Method for controlling liposome size
WO2001032145A1 (en) * 1999-10-29 2001-05-10 Board Of Regents, The University Of Texas System Method of cancer treatment
EP1138312A1 (de) * 2000-03-28 2001-10-04 Primacare S.A. Pro-liposomen
US6761901B1 (en) 2000-05-02 2004-07-13 Enzrel Inc. Liposome drug delivery
US20020007055A1 (en) * 2000-05-15 2002-01-17 Hirotaka Uchiyama Compositions comprising cyclodextrin
US8658202B2 (en) * 2001-04-25 2014-02-25 Western University Of Health Sciences Coated drug delivery formulations
CN1245153C (zh) * 2002-06-06 2006-03-15 上海家化联合股份有限公司 一种维生素a脂质体及其制备方法
EP1543841A4 (en) * 2002-08-15 2011-03-16 Yunqing Liu SOLID PHARMACEUTICAL NANO FORMULATION AND MANUFACTURING METHOD THEREFOR
AU2004235781A1 (en) * 2003-05-02 2004-11-18 Aronex Pharmaceuticals, Inc. Lipid platinum complexes and methods of use thereof
AU2003239511A1 (en) * 2003-05-20 2004-12-13 Aronex Pharmaceuticals, Inc. Combination chemotherapy comprising a liposomal platinum complex
US20080026045A1 (en) * 2003-05-20 2008-01-31 Jonathan Lewis Combination Chemotherapy Comprising a Gemcitabine and a Liposomal Platium Complex
WO2004105747A1 (en) * 2003-05-20 2004-12-09 Aronex Pharmaceuticals, Inc Combination chemotherapy comprising capecitabine and a liposomal platinum complex
CA2526289A1 (en) * 2003-05-20 2004-12-02 Aronex Pharmaceuticals, Inc. Combination chemotherapy comprising 5-fluorouracil or a derivative thereof and a liposomal platinum complex
EP1643972A4 (en) * 2003-06-27 2010-01-20 Smithkline Beecham Corp STABILIZED LIPOSOMAL TOPOTECAN COMPOSITION AND METHOD
US20060002994A1 (en) * 2004-03-23 2006-01-05 Thomas James L Responsive liposomes for ultrasonic drug delivery
MX2010005862A (es) * 2007-11-30 2010-11-30 Endo Pharmaceuticals Solutions Composiciones intravesicales con valrubicina para el tratamiento del cancer de vejiga.
AU2010255391C1 (en) * 2009-06-03 2016-10-27 Sequessome Technology Holdings Limited Formulations for the treatment of deep tissue pain
US9687550B2 (en) 2009-12-07 2017-06-27 Arbutus Biopharma Corporation Compositions for nucleic acid delivery
GB201205642D0 (en) 2012-03-29 2012-05-16 Sequessome Technology Holdings Ltd Vesicular formulations
AU2014340568B2 (en) * 2013-10-22 2017-02-02 Aradigm Corporation Inhaled surfactant-modified liposomal formulations providing both an immediate and sustained release profile
CA2943201A1 (en) * 2014-04-08 2015-10-15 Aradigm Corporation Liposomes that form drug nanocrystals after freeze-thaw
US20160120806A1 (en) * 2014-04-08 2016-05-05 Aradigm Corporation Nanocrystals formed in a microenvironment
AU2015244275B2 (en) 2014-04-08 2019-08-29 Aradigm Corporation Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria
DK3316857T3 (da) 2015-06-30 2021-10-18 Sequessome Tech Holdings Limited Multifasiske sammensætninger
PE20181445A1 (es) * 2016-01-07 2018-09-12 Univ Western Health Sciences Formulaciones para el tratamiento del cancer de vejiga
AU2017382281B2 (en) 2016-12-22 2024-07-11 Genentech, Inc. Methods and formulations for reducing reconstitution time of lyophilized polypeptides
US11458092B2 (en) * 2018-12-14 2022-10-04 NuVessl, Inc. Composition with enhanced passenger molecule loading
EP3990041B1 (en) * 2019-06-28 2025-08-06 Board of Regents, The University of Texas System Method of reconstituting liposomal annamycin
WO2020264160A1 (en) 2019-06-28 2020-12-30 Donald Picker Preparation of preliposomal annamycin lyophilizate
CN114728942A (zh) 2019-11-21 2022-07-08 德州大学系统董事会 用脂质体安那霉素的靶向肺的抗癌疗法

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1575343A (en) * 1977-05-10 1980-09-17 Ici Ltd Method for preparing liposome compositions containing biologically active compounds
US4201773A (en) * 1978-07-26 1980-05-06 The United States Of America As Represented By The Department Of Health, Education And Welfare 7-O-(2,6-Dideoxy-α-L-lyxo-hexopyranosyl)-daunomycinone, desmethoxy daunomycinone, adriamycinone, and carminomycinone
US4522803A (en) * 1983-02-04 1985-06-11 The Liposome Company, Inc. Stable plurilamellar vesicles, their preparation and use
BG38660A1 (en) * 1983-01-11 1986-02-14 Petkov Machine for hydroplastic processing of tube items
JPS6058915A (ja) * 1983-09-12 1985-04-05 Fujisawa Pharmaceut Co Ltd 薬物含有脂質小胞体製剤
JPS60155109A (ja) * 1984-01-23 1985-08-15 Terumo Corp リポソ−ム製剤
US4537882A (en) * 1984-05-10 1985-08-27 Ohio State University 4-Demethoxy-3'-desamino-2'-halo-anthracycline and pharmaceutical composition containing same
CA1264668A (en) * 1984-06-20 1990-01-23 Pieter R. Cullis Extrusion techniques for producing liposomes
ZW3385A1 (en) * 1985-03-01 1986-09-24 David John Fluck Liposomes,process for their preparation and compositions containing them
US4975282A (en) * 1985-06-26 1990-12-04 The Liposome Company, Inc. Multilamellar liposomes having improved trapping efficiencies
GB8516859D0 (en) 1985-07-03 1985-08-07 Secretary Trade Ind Brit Cam follower mechanisms
DE3689769T2 (de) * 1985-07-05 1994-07-21 Liposome Co Inc Multilamellare liposome mit verbesserter einschliessungswirkung.
JPS6295134A (ja) * 1985-10-21 1987-05-01 Nippon Saafuakutanto Kogyo Kk リポソ−ムの製造法
US4812312A (en) * 1987-03-03 1989-03-14 Board Of Regents Of The University Of Texas System Liposome-incorporated nystatin
NZ223660A (en) * 1987-03-05 1990-11-27 Liposome Co Inc Low toxicity drug-lipid complexes; methods of making them; and method of determining their toxicity
US4911928A (en) * 1987-03-13 1990-03-27 Micro-Pak, Inc. Paucilamellar lipid vesicles
US4855090A (en) * 1987-03-13 1989-08-08 Micro-Pak, Inc. Method of producing high aqueous volume multilamellar vesicles
US5811119A (en) * 1987-05-19 1998-09-22 Board Of Regents, The University Of Texas Formulation and use of carotenoids in treatment of cancer
US4863739A (en) * 1987-05-19 1989-09-05 Board Of Regents, The University Of Texas System Liposome compositions of anthracycline derivatives
US4950432A (en) * 1987-10-16 1990-08-21 Board Of Regents, The University Of Texas System Polyene microlide pre-liposomal powders
US5178875A (en) * 1991-01-14 1993-01-12 The Board Of Regents, The University Of Texas System Liposomal-polyene preliposomal powder and method for its preparation
AU608415B2 (en) * 1988-01-19 1991-03-28 University Of Texas System, The Esters of 3'-deaminodoxorubicin, liposomal compositions thereof
CA1335077C (en) * 1988-02-08 1995-04-04 Henri Isliker Process for the manufacture of apolipoproteins from human blood plasma or serum
CA1340241C (en) * 1988-06-08 1998-12-15 Fountain Pharmaceuticals, Inc. Method for marking solvent dilution microcarriers
US4999199A (en) * 1988-11-10 1991-03-12 Board Of Regents, The University Of Texas System Pharmaceutical formulations: liposomes incorporating aromatic polyene antibiotics
US5032404A (en) * 1989-02-23 1991-07-16 Board Of Regents, The University Of Texas System Lipsome-incorporation of polyenes
US5585112A (en) * 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
JPH06183953A (ja) * 1991-06-24 1994-07-05 Nippon Oil & Fats Co Ltd 混合脂質膜小胞
JPH06293615A (ja) * 1992-08-25 1994-10-21 Nippon Oil & Fats Co Ltd 混合脂質膜小胞を含有する化粧品
JPH06227966A (ja) * 1993-01-29 1994-08-16 Advanced Sukin Res Kenkyusho:Kk 温度感受性リポソーム製剤
FR2700954B1 (fr) * 1993-01-29 1995-04-28 Eve International Sa Composition cosmétique à action réparatrice et protectrice des cheveux secs et très secs.
DE4306475A1 (de) * 1993-03-02 1994-09-08 Ensenat Pedro Gonzalez Liposomen, enthaltend Chlorhexidindiacetat oder Chlorhexidindigluconat
EP0706374B1 (en) * 1993-06-30 1997-12-10 Genentech, Inc. Method for preparing liposomes
US5820880A (en) * 1995-06-07 1998-10-13 The United States Of America As Represented By The Secretary Of The Army Liposomal formulation

Also Published As

Publication number Publication date
AU710113B2 (en) 1999-09-16
AU6108796A (en) 1996-12-24
JPH11507369A (ja) 1999-06-29
EP0831781A1 (en) 1998-04-01
WO1996039121A1 (en) 1996-12-12
EP1800665A3 (en) 2008-06-04
US5902604A (en) 1999-05-11
EP1800665A2 (en) 2007-06-27
CA2221341A1 (en) 1996-12-12
US7238366B1 (en) 2007-07-03

Similar Documents

Publication Publication Date Title
CA2221341C (en) Submicron liposome suspensions obtained from preliposome lyophilizates
Mayhew et al. Pharmacokinetics and antitumor activity of epirubicin encapsulated in long‐circulating liposomes incorporating a polyethylene glycol‐derivatized phospholipid
Sharma et al. An Updated Review on: Liposomes as drug delivery system
JP2882607B2 (ja) リポソーム性抗腫瘍剤の高薬剤：脂質調剤
JP2958774B2 (ja) アンホテリシンｂリポソームの改良調整法
AU717181B2 (en) Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizers
WO1987001933A1 (en) Stabilized liposome/amphotericin composition and method
JPH0768119B2 (ja) 単一相中で調製された脂質小胞類
IE67152B1 (en) Low toxicity drug-lipid systems
AU5429800A (en) Method of regulating leakage of drug encapsulated in liposomes
JP2677576B2 (ja) 非水溶性の有効成分のためのリン脂質輪送ビヒクル
EP0800822B1 (en) Method for preparing closed vesicles by rehydration of dehydrated vesicles
JP2006510674A (ja) 脂質：エモジン製剤に関する組成物および方法
Zou et al. Lyophilized preliposomal formulation of the non-cross-resistant anthracycline annamycin: effect of surfactant on liposome formation, stability and size
JP2025026896A (ja) リポソームドキソルビシン製剤、リポソームドキソルビシン製剤の製造方法、および薬剤としてのリポソームドキソルビシン製剤の使用
US20090011001A1 (en) Manufacturing process for liposomal preparations
Priebe Submicron liposome suspensions obtained from preliposome lyophilizates
JP3693209B2 (ja) 閉鎖小胞の製造方法
Hasan et al. Liposomes: an advance tools for novel drug delivery system
JP2002509866A (ja) リポソーム様作用物質調剤の製造法
JPH06502623A (ja) 安定なドキソルビシン／リポソーム組成物
US20020016302A1 (en) Liposomal antitumor drug and its preparation
EP1089727B1 (en) Liposomal formulations of busulphan
WO1993023016A1 (en) Liposomal formulations containing rifamycins
Tinkal et al. LIPOSOMAL DRUG DELIVERY SYSTEM-A REVIEW

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20150608